Pfizer Stock News

Pfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20049.17 Crore) operating in Pharmaceuticals sector.

Arena Pharmaceuticals (ARNA) rose 1.1% in after hours trading after a Nasdaq delisting notice indicated the company''s last trading day would be Thursday due to the completion of its sale…

TALLAHASSEE, Fla. (AP) — Florida Surgeon General Dr. Joseph Ladapo on Tuesday released guidance recommending against vaccinations for healthy children, contradicting federal public health leaders whose advice says all kids should get the shots. The new state Department of Health guidance says healthy children ages 5 to 17 may not benefit from receiving the vaccine. Children with underlying health conditions or comorbidities should consider a COVID-19 vaccine in consultation with their health care provider, the guidance said. The federal Centers for Disease Control and Prevention recommends coronavirus vaccines for everyone 5 years and older, saying the shots provide strong protection against hospitalization and death. The Food and Drug Administration cleared the use of Pfizer’s COVID-19 vaccine in children as young as 5 based on a study showing the child-size doses were 91% effective at preventing symptomatic COVID-19. Ladapo previewed the guidance Monday during a roundtable discussion organized by Republican Gov.

Pfizer (PFE) will soon have data on the efficacy of a fourth COVID shot that it will submit to the U.S. FDA.

Former White House adviser and top Trump negotiator Jared Kushner played the key role in doubling the number of Pfizer vaccine doses the firm initially set aside for Americans, a move that may have helped slow the coronavirus spread much faster, according to a new book.

When Trump forgot to order extra vaccines, Jared Kushner wanted to push to the front of the line. Veuer’s Tony Spitz has the details.

Futures Rebound On "Massive" EU Bond Stimulus Plan; Nickel Halted After Record Surge, Gold Over $2000 Futures rebounded from yesterday huge loss, and after touching a session low of 4,138, S&P futures bounced shortly after the European when Bloomberg reported that the European Union was set to reveal a quasi "Marshall Plan" this week to issue issue "potentially massive” joint bonds to fund energy and defense and help counter the fiscal fallout from Russia’s invasion of Ukraine (how Europe will do that at a time when QE is ending and buyers for global debt are shrinking fast amid surging rates remains unclear). S&P 500 futures gained 0.7% following the benchmark index’s biggest loss since October 2020, while Dow futures rose 0.6%. Contracts on the Nasdaq 100 were up 0.6% at 7:15 a.m. Bonds and the dollar dropped, and the euro strengthened. The commodity melt up continued: nickel was halted on the LME after soaring 250%, oil traded just shy of $130 and gold was above $2000. The EU''s bond-sale proposal may be presented as soon as next week, according to Bloomberg.

When the stakes are high, even big, bureaucratic organizations can find the urgency to make bold moves. Read More

Shares of state-owned China Meheco Co. shot up more than 50% in the past week amid speculation that the Beijing-based drug maker will be the local partner for Pfizer Inc.’s Covid-19 treatment pill.

Per Bourla, Kushner thought the US should come first and said the US government could "take measures" to enforce its will and get the COVID-19 jabs.

The CDC says 92% of reported side effects after the Pfizer and Moderna vaccines are mild.

Regional leaders from Pfizer in Africa and the Middle East region (AfME) has announced plans on delivering breakthroughs to more patients across the region, aiming to impact over 45 percent people in 2022. “As we continue to raise the bar within science and patient impact in the region, we are seeking even stronger collaborations with […]

Pfizer Covid shots, sparkling clean streets and tax-free policies are among the draws. And for investors with US$2.7 million to spare, there are ‘Golden Visas’, too.

Intranasal sprays might be more effective than jabs.